Achilles tendinopathy is a prevalent condition characterized by pain, swelling, and impaired function of the Achilles tendon, commonly affecting athletes and active individuals. The disorder arises from a failed healing response, leading to degenerative changes in the tendon without significant inflammation. It is categorized into insertional (at the calcaneus-Achilles junction) and non-insertional (2-6 cm proximal to the insertion) types. Intrinsic risk factors include biomechanical abnormalities and systemic conditions like diabetes and hypertension, while extrinsic factors involve excessive mechanical load and training errors. Effective management of Achilles tendinopathy is crucial for preventing long-term disability and ensuring the continuation of physical activities.
Age of patients 18-40.
Diagnosed with chronic Achillis tendinopathy and NPRS rating more than 2.
Both male and female.
Patient must be diagnosed with Achillis Tendinopathy by single leg raise or Thompson test.
contraindications to LLLT to the area of the Achilles tendon.
comorbid musculoskeletal or serious conditions that may have confounded treatment or anticipated recovery .
nonsteroidal anti-inflammatory drug use steroid injections or surgery for the condition; insertional tendinopathy or bursitis (retrocalcaneal or Achilles; determined by clinical examination.
neurologic signs; and adverse neural tension affecting the sciatic or sural nerve.